UBS’s LIPOSCIENCE INC COM LPDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$103K Buy
19,949
+5,910
+42% +$19.3K ﹤0.01% 5961
2014
Q2
$48K Sell
14,039
-18,830
-57% -$60.5K ﹤0.01% 6939
2014
Q1
$105K Buy
32,869
+13,872
+73% +$58.2K ﹤0.01% 5922
2013
Q4
$81K Buy
18,997
+13,335
+236% +$58.6K ﹤0.01% 6335
2013
Q3
$29K Sell
5,662
-11,862
-68% -$66.4K ﹤0.01% 7605
2013
Q2
$122K Buy
+17,524
New +$134K ﹤0.01% 5674

Other funds holding LPDX

UBS's LPDX Position: Q3 2014 in Review

UBS increased its LIPOSCIENCE INC COM (LPDX) stake by 42% in Q3 2014, buying an estimated $19.3K and bringing the position to 19,949 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #5961.

UBS first reported a position in LPDX in Q2 2013 and has held it in 6 quarters since. The position peaked at $122K in Q2 2013. 34 funds tracked by Wall St. Rank hold LPDX as of Q3 2014.

  • UBS held 19,949 shares of LIPOSCIENCE INC COM worth $103K as of Q3 2014.
  • UBS bought 5,910 LIPOSCIENCE INC COM shares in Q3 2014, an estimated $19.3K.
  • LIPOSCIENCE INC COM made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5961 holding.
  • UBS first reported a position in LIPOSCIENCE INC COM in Q2 2013 and has held it in 6 quarters since.
  • UBS's LIPOSCIENCE INC COM position peaked at $122K in Q2 2013.
  • 34 funds tracked by Wall St. Rank held LIPOSCIENCE INC COM as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.